269 related articles for article (PubMed ID: 28381743)
1. Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.
Yamada K; Namikawa H; Fujimoto H; Nakaie K; Takizawa E; Okada Y; Fujita A; Kawaguchi H; Nakamura Y; Abe J; Kaneko Y; Kakeya H
Intern Med; 2017; 56(7):781-785. PubMed ID: 28381743
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
3. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities].
Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F
Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus.
Falcone M; Micozzi A; Pompeo ME; Baiocchi P; Fabi F; Penni A; Martino P; Venditti M
J Chemother; 2004 Dec; 16(6):540-8. PubMed ID: 15700845
[TBL] [Abstract][Full Text] [Related]
5.
Plota M; Papadimitriou-Olivgeris M; Kolonitsiou F; Tsiata E; Spiliopoulou I; Assimakopoulos SF; Marangos M
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34559042
[No Abstract] [Full Text] [Related]
6. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
Cui J; Liang Z; Mo Z; Zhang J
Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
[TBL] [Abstract][Full Text] [Related]
7. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
9. Non- epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia.
Ruhe J; Menon A; Mushatt D; Dejace P; Hasbun R
Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):495-8. PubMed ID: 15141334
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey.
Koksal F; Yasar H; Samasti M
Microbiol Res; 2009; 164(4):404-10. PubMed ID: 17475456
[TBL] [Abstract][Full Text] [Related]
11. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
[TBL] [Abstract][Full Text] [Related]
12. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
13. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.
Tacconelli E; Tumbarello M; Donati KG; Bettio M; Spanu T; Leone F; Sechi LA; Zanetti S; Fadda G; Cauda R
Clin Infect Dis; 2001 Nov; 33(10):1628-35. PubMed ID: 11595984
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
15. Coagulase negative staphylococci - a fast emerging threat.
Latif M; Usman J; Gilani M; Munir T; Mushtaq M; Anjum R
J Pak Med Assoc; 2015 Mar; 65(3):283-6. PubMed ID: 25933562
[TBL] [Abstract][Full Text] [Related]
16. Teicoplanin in infections caused by methicillin-resistant staphylococci.
Drabu YJ; Walsh B; Blakemore PH; Mehtar S
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():89-92. PubMed ID: 2965136
[TBL] [Abstract][Full Text] [Related]
17. Glycopeptides in the treatment of staphylococcal infections.
Daschner FD; Kropec A
Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
[TBL] [Abstract][Full Text] [Related]
18. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
[TBL] [Abstract][Full Text] [Related]
19. Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece.
Liakopoulos V; Petinaki E; Efthimiadi G; Klapsa D; Giannopoulou M; Dovas S; Eleftheriadis T; Mertens PR; Stefanidis I
Nephrol Dial Transplant; 2008 Aug; 23(8):2599-603. PubMed ID: 18305314
[TBL] [Abstract][Full Text] [Related]
20. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
